FibroGen (FGEN) – Research Analysts’ Recent Ratings Changes
FibroGen (NASDAQ: FGEN) recently received a number of ratings updates from brokerages and research firms: 4/1/2025 – FibroGen had its “market perform” rating reaffirmed by analysts at William Blair. 3/30/2025 – FibroGen is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 3/22/2025 – FibroGen is now covered by analysts […]
FibroGen (NASDAQ: FGEN) recently received a number of ratings updates from brokerages and research firms: 4/1/2025 – FibroGen had its “market perform” rating reaffirmed by analysts at William Blair. 3/30/2025 – FibroGen is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 3/22/2025 – FibroGen is now covered by analysts […]
